Stock NATCOPHARM NATCO PHARMA LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart NATCO Pharma Limited

Equities

NATCOPHARM

INE987B01026

Delayed NSE India S.E.
Other stock markets
 04:08:50 2024-05-23 EDT 		5-day change 1st Jan Change
1,019 INR +1.55% Intraday chart for NATCO Pharma Limited +2.31% +25.95%
05-08 AstraZeneca, Merck Sue to Protect Lynparza Cancer Drug Patents MT
05-08 AstraZeneca, Merck Sue to Protect Lynparza Cancer Drug Patents MT
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Other Pharmaceuticals

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
NATCO PHARMA LIMITED Stock NATCO Pharma Limited
 2.16B
ELI LILLY AND COMPANY Stock Eli Lilly and Company
 723B
NOVO NORDISK A/S Stock Novo Nordisk A/S
 595B
JOHNSON & JOHNSON Stock Johnson & Johnson
 369B
MERCK & CO., INC. Stock Merck & Co., Inc.
 332B
ABBVIE INC. Stock AbbVie Inc.
 282B
  1. Stock Market
  2. Equities
  3. NATCOPHARM Stock
  4. Charts NATCO Pharma Limited
  5. Sector Chart